The Group development projects are relating to both new proprietary products (Active Ingredients) and new formulations; besides, the Group is investing in new production processes.

By the way, Isagro presents two novelties: the expansion of the biosolutions field, such products being intended to gain more and more weight in the Group income statement; the assignment of the new molecules development to third parties, by licensing part of the related exploitation rights as per a business model that focuses on the role of Isagro as originator and pre-developer, at which the company excels, though limiting its commitment to development, which implies huge investments and a long time-to-market lasting 10 – 12 years.